ARHGDIA

Rho GDP dissociation inhibitor alpha

Basic information

Region (hg38): 17:81867719-81871378

Previous symbols: [ "GDIA1" ]

Links

ENSG00000141522NCBI:396OMIM:601925HGNC:678Uniprot:P52565AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • nephrotic syndrome, type 8 (Moderate), mode of inheritance: AR
  • familial idiopathic steroid-resistant nephrotic syndrome (Supportive), mode of inheritance: AD
  • nephrotic syndrome, type 8 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Nephrotic syndrome, type 8ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingRenal23434736; 23867502
Renal transplant has been described

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ARHGDIA gene.

  • not_provided (31 variants)
  • Inborn_genetic_diseases (24 variants)
  • ARHGDIA-related_disorder (7 variants)
  • Nephrotic_syndrome,_type_8 (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGDIA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004309.6. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
13
clinvar
2
clinvar
16
missense
1
clinvar
31
clinvar
32
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
Total 2 0 33 13 2

Highest pathogenic variant AF is 0.0000027368055

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ARHGDIAprotein_codingprotein_codingENST00000269321 53686
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.03640.932125734061257400.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.20871250.6970.000007481329
Missense in Polyphen2342.8530.53672522
Synonymous-3.358755.31.570.00000374382
Loss of Function1.86410.50.3805.75e-7117

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.00009960.0000992
East Asian0.0001090.000109
Finnish0.00004630.0000462
European (Non-Finnish)0.000008790.00000879
Middle Eastern0.0001090.000109
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Controls Rho proteins homeostasis. Regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. Retains Rho proteins such as CDC42, RAC1 and RHOA in an inactive cytosolic pool, regulating their stability and protecting them from degradation. Actively involved in the recycling and distribution of activated Rho GTPases in the cell, mediates extraction from membranes of both inactive and activated molecules due its exceptionally high affinity for prenylated forms. Through the modulation of Rho proteins, may play a role in cell motility regulation. In glioma cells, inhibits cell migration and invasion by mediating the signals of SEMA5A and PLXNB3 that lead to inactivation of RAC1. {ECO:0000269|PubMed:20400958, ECO:0000269|PubMed:23434736}.;
Disease
DISEASE: Nephrotic syndrome 8 (NPHS8) [MIM:615244]: A form of nephrotic syndrome, a renal disease clinically characterized by progressive renal failure, severe proteinuria, hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show diffuse mesangial sclerosis, with small glomeruli, hypercellularity, increased extracellular matrix, and contracted/collapsed glomerular tufts surrounded by immature or abnormal podocytes. {ECO:0000269|PubMed:23434736}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Neurotrophin signaling pathway - Homo sapiens (human);Vasopressin-regulated water reabsorption - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases;Regulation of RAC1 activity;Death Receptor Signalling;Axonal growth stimulation;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Regulation of CDC42 activity;PAR1-mediated thrombin signaling events;RAC1 signaling pathway;CDC42 signaling events;p75(NTR)-mediated signaling;PDGFR-beta signaling pathway;Regulation of RhoA activity (Consensus)

Intolerance Scores

loftool
0.222
rvis_EVS
-0.25
rvis_percentile_EVS
35.42

Haploinsufficiency Scores

pHI
0.109
hipred
Y
hipred_score
0.783
ghis
0.648

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.973

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Arhgdia
Phenotype
immune system phenotype; renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
arhgdia
Affected structure
whole organism
Phenotype tag
abnormal
Phenotype quality
edematous

Gene ontology

Biological process
negative regulation of cell adhesion;Rho protein signal transduction;regulation of Rho protein signal transduction;negative regulation of apoptotic process;positive regulation of GTPase activity;negative regulation of axonogenesis;positive regulation of axonogenesis;regulation of small GTPase mediated signal transduction;semaphorin-plexin signaling pathway;regulation of actin cytoskeleton reorganization
Cellular component
cytosol;cytoskeleton;membrane;extracellular exosome
Molecular function
Rho GDP-dissociation inhibitor activity;GTPase activator activity;protein binding;Rac GTPase binding